The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-1-(4-methoxyphenyl)-4-(1-phenoxypropan-2-yloxy)pyridin-2(1H)-one ID: ALA4574649
PubChem CID: 155563969
Max Phase: Preclinical
Molecular Formula: C21H21NO4
Molecular Weight: 351.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(-n2ccc(O[C@H](C)COc3ccccc3)cc2=O)cc1
Standard InChI: InChI=1S/C21H21NO4/c1-16(15-25-19-6-4-3-5-7-19)26-20-12-13-22(21(23)14-20)17-8-10-18(24-2)11-9-17/h3-14,16H,15H2,1-2H3/t16-/m1/s1
Standard InChI Key: NUESXZYGSOAJKX-MRXNPFEDSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
11.2123 -5.2993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2111 -6.1189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9192 -6.5278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6288 -6.1184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6260 -5.2957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9174 -4.8905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3322 -4.8845 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0414 -5.2904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7476 -4.8791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4568 -5.2851 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.1630 -4.8738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8682 -5.2806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5722 -4.8728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5734 -4.0553 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8643 -3.6472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1540 -4.0566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8640 -2.8300 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.2811 -3.6467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9855 -4.0584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6927 -3.6505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6932 -2.8325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9805 -2.4240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2762 -2.8343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7445 -4.0619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4004 -2.4229 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.1086 -2.8306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
11 16 2 0
12 13 2 0
13 14 1 0
14 15 1 0
15 16 1 0
15 17 2 0
14 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
9 24 1 1
21 25 1 0
25 26 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 351.40Molecular Weight (Monoisotopic): 351.1471AlogP: 3.69#Rotatable Bonds: 7Polar Surface Area: 49.69Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.52CX LogD: 3.52Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.65Np Likeness Score: -0.86
References 1. Yamada Y, Yohn SE, Gilliland K, Loch MT, Schulte ML, Rodriguez AL, Blobaum AL, Niswender CM, Conn PJ, Lindsley CW.. (2019) Further exploration of an N-aryl phenoxyethoxy pyridinone-based series of mGlu3 NAMs: Challenging SAR, enantiospecific activity and in vivo efficacy., 29 (18): [PMID:31358468 ] [10.1016/j.bmcl.2019.07.030 ]